Insulin Delivery Systems: Market Research Report

April 2010 | 435 pages | ID: I6DDBEFA8D6EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Insulin Delivery Systems in US$ Million by the following major Insulin Delivery Mechanisms - Insulin Syringes, Insulin Pumps (External), and Insulin Pens.

The report provides separate comprehensive analytics for US, Europe, and Rest of World.

Annual forecasts are provided for each region for the period 2007 through 2015.

Also, a six-year historic analysis is provided for these markets.

The report profiles 72 companies including many key and niche players worldwide such as Animas Corporation, Antares Pharma, Inc., Becton, Dickinson and Company, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Disetronic Medical Systems, Inc., Generex Biotechnology Corp., Insulet Corp, Medical Plastic Devices Inc., Medtronic Inc., Novo Nordisk A/S, Patton Medical Devices, LP, Sanofi-Aventis, Smiths Medical MD, Inc., and Ypsomed AG.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Increasing Diabetes Prevalence – A Major Growth Propeller
Diabetes – Taking Toll in Developing Countries
Insulin Therapy for Diabetes Management
Insulin Delivery Systems – A Quick Market Primer
Insulin Pump Therapy: Convenient Alternate to Insulin Injection
United States – The Largest Global Market for Insulin Pumps (External)
Rosy Future Ahead for Insulin Pens
Select Brands of Disposable Insulin Pens by Manufacturer
Select Brands of Reusable Insulin Pens by Manufacturer
Innovations in Insulin Delivery – An Overview
Select Next-Generation Insulin Delivery Techniques and Devices
Pulmonary Insulin Delivery via Inhalers
Early Jitters Make Pharma Majors Abandon Inhaled Insulin Research
Pulmonary Insulin Delivery Research Still Remains Unabated
Transdermal Delivery of Insulin via Patches
Transmucosal Insulin Delivery via Mouth Spray
Nasal Delivery of Insulin via Nasal Mucosa
Hydrogels for Insulin Delivery
Oral Insulin Delivery
Artificial Pancreas Technology – A Promising Approach for Diabetes Treatment
Competitive Landscape
Insulin Syringes
Insulin Pumps
Insulin Pens

2.MAJOR TRENDS & ISSUES

Pre-Filled Syringes: Gaining Diabetics Attention
Insulin Pumps Market: Tough Ground for New Entrants
Innovative Features Spruce Up the Market for Insulin Pumps
Combination Products: The Latest Trend in the Insulin Pump Market
Implantable Insulin Pumps: Emerging Technology in the Insulin Pump Market
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
Insulin Pump Market Issues
Insulin Pump Training Not Receiving Adequate Attention
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged

3.DIABETES & INSULIN DELIVERY SYSTEMS - AN ABSTRACT

Diabetes - A Fatal Disease
Risk Factors for Diabetes
Types of Diabetes
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM)
Long Term Complications of Diabetes
Pancreas: The Main Source of Insulin in Human Body
Types of Insulin & Administration
Oral Administration
Goal of Insulin Therapy
Insulin Delivery Systems – An Overview
Insulin Syringes
Insulin Needles
Insulin Pens
Advantages of Insulin Pens
Disadvantages of Insulin Pens
External Insulin Pumps
Insulin Pump Components
How Does an Insulin Pump Work?
Insulin Pump Delivery Rates
Advantages of Insulin Pumps
More Accurate and Consistent
Adjusting Time Zones While Traveling
Enhances Blood Sugar Control in Pediatric Patients
Improves Quality of Life
Disadvantages of Insulin Pumps
High Cost
High Involvement
Diabetic Ketoacidosis Risk
Glucose Testing at Regular Intervals
Regular Rotation of Infusion Set
Carrying Back-up Kit
Regular Refilling of Pump
Insulin Jet Injectors
Pen Injectors

4.RESEARCH & DEVELOPMENT

Nanotechnology Victoria, Monash University Develop SAW Generated Mechanism, for Insulin Delivery
Medtronic Emphasizes Cutting-Edge Features of a Closed-Loop Diabetes Management System, Currently Under Development
Toray Industries and Hoshi University Discover a New Approach for Insulin Delivery Via Nasal Spray
A New Study Demonstrates Superior Benefits of Novo Nordisk's Next Generation
Phosphagenics to Commence Phase II Clinical Trials of Transdermal Insulin Delivery System
Oramed Pharmaceuticals Begins Phase Ia Trials of Insulin Suppository
Debiotech and STMicroelectronics Unveil First Prototype of a Disposable Insulin Nanopump
Braunschweig University Scholar Devises Wristwatch Insulin Pump

5.PRODUCT INTRODUCTIONS

Novo Nordisk Introduces Preloaded Pen
BD Medical Unveils BD AutoShield Pen Needle
Novo Nordisk Introduces Flexpen
Polymedicure Unveils Insulin syringes
Johnson & Johnson Medical India to Unveil Insulin Pumps
Generex Rolls Out Oral Insulin Spray
Eli Lilly Launches KwikPen
Smith Medical Launches Cozmo in China
Medtronic Unveils Arabic Language Insulin Pump
Medtronic Launches New Diabetes Monitoring System
Eli Lilly to Unveil New Insulin Pen, Memoir

6.RECENT INDUSTRY ACTIVITY

JDRF Enters into Partnership with Animas
Medtronic Acquires Certain Assets from PreciSense
MannKind Inks Agreement to Acquire Pfizer’s German Insulin Facility
Owen Mumford Inks Deal with Sanofi-Aventis
Medingo Obtains FDA Approval for Marketing Insulin Micropump
Insulet Wins CE Mark Approval for OmniPod® Insulin Management System
Sanofi-aventis Receives FDA Approval for Apidra® SoloSTAR®
Novo Nordisk Receives FDA Approval for NovoLog® Labeling Change
Patton Medical Devices, Unomedical Enter into Partnership Agreement
Sanofi-aventis Wins Canadian and EU Approval for ClikSTAR® Insulin Pen
DexCom and Animas Amend Insulin Pump Joint Development Deal
Medingo Secures FDA Approval for Solo MicroPump Insulin Delivery System
Qualitest Pharmaceuticals Recalls Accusure Insulin Syringes
Novartis Completes Acquisition of Nektar’s Pulmonary Business
Smiths Medical Acquires Zhejiang Zheda Medical Instrument
ICBS Acquires Vectoris Pharma
Sagent Pharma Acquires Rights to ChaSyr, a Multi-Chamber Syringe
Novo Nordisk Hands Over Inhaled Insulin Patents to Aradigm
Eli Lilly and Alkermes Terminate Inhaled Insulin Development Deal
Novo-Nordisk Drops Development Plan of Inhaled Insulin
Generex, Dongsung Pharm Enter Agreement for Generex Oral-lyn
Novo Nordisk Gains FDA Clearance for NovoLog®
Novo Nordisk to Construct Insulin Plant in China
Generex Biotechnology Enters into Distribution Agreement with SciGen
Rexam and Eli Lilly to Expand Manufacturing Base for Insulin Pens
Merrion to Develop and Market Novo Nordisk’s Insulin Analogues
Smiths Medical to Cease Insulin Pumps Sale, Exist Diabetes Business
Covidien Recalls Mislabelled Syringes
Animas Recalls Insulin Pumps with Faulty Battery Cap
NationsHealth Acquires Diabetes Care & Education
Insulet Inks Agreement with DexCom
Insulet Partners with Flextronics
Debiotech Allies with STMicroelectronics
SpectRx Divests Insulin Pump Business

7.FOCUS ON SELECT GLOBAL PLAYERS

Animas Corporation (USA)
Antares Pharma, Inc. (USA)
Becton, Dickinson and Company (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche, Ltd. (Switzerland)
Disetronic Medical Systems, Inc. (USA)
Generex Biotechnology Corp. (Canada)
Insulet Corp. (USA)
Medical Plastic Devices Inc. (Canada)
Medtronic Inc. (USA)
Novo Nordisk A/S (Denmark)
Patton Medical Devices, LP (USA)
Sanofi-Aventis (France)
Smiths Medical MD, Inc. (USA)
Ypsomed AG (Switzerland)

8.GLOBAL MARKET PERSPECTIVE

Insulin Syringes:

Table 1. World Recent Past, Current & Future Analysis for Insulin Syringes Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 2. World Historic Review for Insulin Syringes Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

Table 3. World 15-year Perspective for Insulin Syringes Market by Geographic Region – Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)

Insulin Pumps (External):

Table 4. World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 5. World Historic Review for Insulin Pumps (External) Market by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

Table 6. World 15-year Perspective for Insulin Pumps (External) Market by Geographic Region – Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)

Insulin Pens:

Table 7. US and Europe Recent Past, Current & Future Analysis for Insulin Pens Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 8. US and Europe Historic Review for Insulin Pens Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. MARKET ANALYSIS

Diabetes – A Cause of Concern

Table 9. Diabetes Prevalence by Diabetes Type in Millions in the US (2008) (includes corresponding Graph/Chart)

Surging Diabetic Population Keeps Demand Ticking for Insulin Delivery Systems
External Insulin Pumps: A Key Mechanism for Insulin Delivery
Insulin Pens Gaining Immense Prominence
Jet Injectors: The Costliest Insulin Delivery System
Competitive Analysis by Insulin Delivery System
Becton Dickinson – The Insulin Syringes Market Leader

Table 10. US Insulin Syringes Market (2007): Percentage Share Breakdown by Leading Companies - Becton Dickinson, Kendall, and Others (includes corresponding Graph/Chart)

Medtronic – The Insulin Pumps Major

Table 11. US Insulin Pumps Market (2008): Percentage Share Breakdown of Leading insulin Pump Manufacturers – Medtronic, Animas and Others Comparison of Major Insulin Pump Systems Based on Select Parameters (includes corresponding Graph/Chart)

Product Introductions
Strategic Corporate Developments
Major Players

B. MARKET ANALYTICS

Table 12. US Recent Past, Current & Future Analysis for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 13. US Historic Review for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

Table 14. US 10-year Perspective for Insulin Delivery Systems – Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)

2.EUROPE

A. MARKET ANALYSIS

European Preference for Insulin Pens Overshadows the Rest of the World Demand
Insulin Pump Therapy Gaining Favor Among Europeans
Strategic Corporate Developments
Major Players

B. MARKET ANALYTICS

Table 15. Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 16. Europe Historic Review for Insulin Delivery Systems – Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

Table 17. Europe 10-year Perspective for Insulin Delivery Systems – Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)

3.REST OF WORLD

A. MARKET ANALYSIS

Product Introductions
Strategic Corporate Developments
Major Players

B. MARKET ANALYTICS

Table 18. Rest of World Recent Past, Current & Future Analysis for Insulin Delivery Systems – Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 19. Rest of World Historic Review for Insulin Delivery Systems – Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

Table 20. Rest of World 10-year Perspective for Insulin Delivery Systems – Percentage Breakdown of Value Sales for Insulin Syringes and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 72 (including Divisions/Subsidiaries - 82)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Rest of Europe
Asia-Pacific (Excluding Japan)
Middle-East